ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2

Murine Model of Arthritis Flare Identifies CD8+ Tissue Resident Memory T Cells in Recurrent Synovitis

Margaret H Chang1, Anais Levescot2, Allyn Morris2, Nathan Nelson-Maney3, Robert Fuhlbrigge4 and Peter A. Nigrovic2, 1Immunology, Boston Children's Hospital, Boston, MA, 2Rheumatology, Immunology, and Allergy, Brigham and Women’s Hospital, Boston, MA, 3Division of Rheumatology, Immunology, and Allergy, Brigham and Women’s Hospital, Boston, MA, 4Children's Hospital Colorado, Aurora, CO

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: arthritis and memory, T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Thursday, May 18, 2017

Title: Plenary Abstract Session 1

Session Type: Abstract Submissions

Session Time: 2:00PM-3:00PM

Background/Purpose: There are 75,000 children affected by JIA in the United States. Despite recent therapeutic advances, treatment often requires chronic therapy and is associated with considerable cost and morbidity, yet is still not curative as episodic flares are common. However, the pathophysiology of these flares is not well understood. There is a common observation that arthritis flares exhibit a strong tendency to recur in the same joints. This fixed pattern of joint involvement is highly individualized and persists for decades. To study this phenomenon, we established a murine model of recurrent, joint-specific inflammation.

Methods: Methylated bovine serum albumin (meBSA) or ovalbumin (OVA) is injected into the wrist, knee and ankle joints of B6 mice. The contralateral side was injected with vehicle as a negative control. For the OVA conditions, 5×10^6 CD3+ cells collected from peripheral lymph nodes of OT-I mice were transferred IV into the mice 1 day prior to intra-articular OVA injection. Interleukin-1 was concurrently injected into the footpad of the mice to stimulate the immune response. Arthritis flare was triggered by i.p. meBSA or OVA re-stimulation. At days 7 (acute inflammation), 28 (remission) and 31 (flare), the joints were analyzed for inflammation by measuring joint thickness, histological evaluation, and flow cytometry analysis of disaggregated synovium.

Results: 7 days after injection, there is measureable swelling and histological evidence of synovitis, specifically in the joints exposed to the antigen. In the synovium, there is a corresponding increase in CD4 and CD8 T cell populations. At 28 days after injection, inflammation subsides with normalization of both joint size and resolution of synovitis. During this post-inflammatory remission, we found a persistent population of antigen-specific cells with resident memory T cell (TRM) phenotype (CD45.2+CD3+CD8+CD44+CD62L-CD69+CD103+). These TRM cells are preferentially increased in the synovium of the joint exposed to antigen. Upon intraperitoneal challenge with antigen, there is a recurrent inflammation specifically in the joints previously exposed to antigen, and a corresponding expansion of antigen-specific CD8+ TRM cells in the synovium is also seen.

Conclusion: Here, we created an inducible model of recurrent, joint-specific inflammation. Our data suggests synovial resident memory T cells may represent the basis for joint-specific memory in inflammatory arthritis.


Disclosure: M. H. Chang, None; A. Levescot, None; A. Morris, None; N. Nelson-Maney, None; R. Fuhlbrigge, None; P. A. Nigrovic, None.

To cite this abstract in AMA style:

Chang MH, Levescot A, Morris A, Nelson-Maney N, Fuhlbrigge R, Nigrovic PA. Murine Model of Arthritis Flare Identifies CD8+ Tissue Resident Memory T Cells in Recurrent Synovitis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/murine-model-of-arthritis-flare-identifies-cd8-tissue-resident-memory-t-cells-in-recurrent-synovitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/murine-model-of-arthritis-flare-identifies-cd8-tissue-resident-memory-t-cells-in-recurrent-synovitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology